CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Deferred Tax Expense from Stock Options Exercised
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Deferred Tax Expense from Stock Options Exercised of $10.61 million for the 12-month period ending 2015-12-26, per its 10-K filed 2016-02-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:DeferredTaxExpenseFromStockOptionsExercised · last filed 2016-02-12
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred tax expense from stock options exercised for fiscal 2015 was $10.61M, a 146.64% increase from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred tax expense from stock options exercised for fiscal 2014 was $4.30M, a 302.34% increase from fiscal 2013.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred tax expense from stock options exercised for fiscal 2013 was $1.07M, a 755.20% increase from fiscal 2012.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred tax expense from stock options exercised for fiscal 2012 was $125.00K.
| Period end | Deferred Tax Expense from Stock Options Exercised 12 month |
|---|---|
| 2015-12-26 | $10.61M 10-K · filed 2016-02-12 |
| 2014-12-27 | $4.30M 10-K · filed 2016-02-12 |
| 2013-12-28 | $1.07M 10-K · filed 2016-02-12 |
| 2012-12-29 | $125.00K 10-K · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |